Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
101,224,395
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
64,112
-
Shares change
-
-31,389
-
Total reported value, excl. options
-
$1,793,086
-
Value change
-
-$751,923
-
Number of buys
-
1
-
Number of sells
-
1
-
Price
-
$27.22
Institutional Holders of Beam Therapeutics Inc. - COMMON STOCK (BEAM) as of Q4 2023
As of 31 Dec 2023 Beam Therapeutics Inc. - COMMON STOCK (BEAM) had 233 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 64,112 shares of stock of the company.
Largest 10 holders included ARK Investment Management LLC, VANGUARD GROUP INC, BlackRock Inc., FMR LLC, STATE STREET CORP, MORGAN STANLEY, FARALLON CAPITAL MANAGEMENT LLC, Temasek Holdings (Private) Ltd, Sumitomo Mitsui Trust Holdings, Inc., and Nikko Asset Management Americas, Inc..
This table shows 233 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.